The city witnessed the first death caused by Guillain-Barré Syndrome (GBS) this year on Monday night, as a 53-year-old man ...

The city witnessed the first death caused by Guillain-Barré Syndrome this year on Monday night, as a 53-year-old man died ...

MUMBAI: A 53-year-old man succumbed to the Guillain-Barre syndrome (GBS) at Nair Hospital on February 10, counting as the first death due to GBS in the city. With this, the total of GBS deaths in ...

A 59-year-old man suffering from Guillain-Barre Syndrome (GBS) has died in a hospital here, taking the death toll due to the ...

A 53-year-old man has died from Guillain-Barre Syndrome (GBS) at a Mumbai hospital, marking the city`s first reported ...

Research published in late 2024 in the journal JAMA Pediatrics found nirsevimab was more than 90 percent effective at preventing hospitalization for RSV, and 89 percent effective at preventing all ...

Emblaveo will be available in the third quarter of 2025 to treat patients with intra-abdominal infections, a common cause of sepsis in the intensive care unit.

A Pune driver succumbed to Guillain-Barre Syndrome (GBS) amid rising cases, with the total reaching 192, including 167 confirmed. Despite treatment efforts, the death toll has climbed to seven. Health ...

Grace Therapeutics' GTx-104 met its Phase 3 trial endpoint, showing clinical benefits over oral nimodipine. US NDA submission ...

Trial Met the Primary Endpoint and Provides Evidence of GTx-104 Clinical Benefit Compared to Orally Administered NimodipineNew Drug Application ...

Grace Therapeutics (GRCE) announced that its Phase 3 STRIVE-ON safety trial met its primary endpoint and provides evidence of clinical benefit ...

The Centers for Disease Control and Prevention lists Illinois in the high category for flu cases, and across the Chicago area ...